Tranquility Partners LLC Has $1.59 Million Stock Holdings in Zoetis Inc. (NYSE:ZTS)

Tranquility Partners LLC reduced its position in shares of Zoetis Inc. (NYSE:ZTS) by 0.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,121 shares of the company’s stock after selling 60 shares during the period. Tranquility Partners LLC’s holdings in Zoetis were worth $1,587,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ZTS. Caprock Group LLC raised its holdings in shares of Zoetis by 7.3% during the 3rd quarter. Caprock Group LLC now owns 11,984 shares of the company’s stock worth $2,342,000 after buying an additional 811 shares in the last quarter. Pathstone Holdings LLC grew its position in Zoetis by 0.5% in the third quarter. Pathstone Holdings LLC now owns 60,660 shares of the company’s stock valued at $11,852,000 after acquiring an additional 310 shares during the last quarter. Quest Partners LLC grew its position in Zoetis by 328.8% in the third quarter. Quest Partners LLC now owns 10,407 shares of the company’s stock valued at $2,033,000 after acquiring an additional 7,980 shares during the last quarter. Alpha Family Trust acquired a new position in Zoetis during the third quarter worth about $213,000. Finally, Turtle Creek Wealth Advisors LLC lifted its holdings in shares of Zoetis by 2.2% in the third quarter. Turtle Creek Wealth Advisors LLC now owns 30,521 shares of the company’s stock worth $5,963,000 after acquiring an additional 664 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. lifted their price target on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Argus raised shares of Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Piper Sandler increased their price target on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. BTIG Research boosted their price objective on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, August 12th. Finally, Stifel Nicolaus upped their target price on Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a report on Wednesday, September 18th. Ten analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Zoetis currently has a consensus rating of “Buy” and an average price target of $221.44.

Zoetis Trading Up 0.7 %

NYSE:ZTS opened at $176.42 on Tuesday. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92. The firm’s fifty day moving average is $186.78 and its 200-day moving average is $180.45. The firm has a market cap of $79.60 billion, a P/E ratio of 33.16, a P/E/G ratio of 2.69 and a beta of 0.90. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. The firm had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The business’s revenue was up 11.6% compared to the same quarter last year. During the same period last year, the business posted $1.36 EPS. Equities analysts expect that Zoetis Inc. will post 5.9 earnings per share for the current year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be issued a dividend of $0.432 per share. This represents a $1.73 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date of this dividend is Thursday, October 31st. Zoetis’s payout ratio is 32.52%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.